Wave Life Sciences Ltd. (WVE)
NASDAQ·Healthcare·Biotechnology
$7.39
+6.41%
Mkt Cap $1.38B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $16.06M | $17.24M | +7.39% | -$0.28 | -$0.30 | -7.14% | — | — |
| Q4 2025 Nov 10, 2025 | $16.35M | $7.61M | -53.45% | -$0.30 | -$0.32 | -6.67% | — | — |
| Q3 2025 Jul 30, 2025 | $9.85M | $8.70M | -11.69% | -$0.29 | -$0.31 | -6.90% | — | — |
| Q2 2025 May 8, 2025 | $14.41M | $9.18M | -36.35% | -$0.27 | -$0.29 | -7.41% | — | — |
| Q1 2025 Mar 4, 2025 | $12.17M | $83.75M | +588.34% | -$0.17 | $0.17 | +200.00% | — | — |
| Q4 2024 Nov 12, 2024 | $25.59M | -$7.68M | -129.99% | -$0.28 | -$0.47 | -67.86% | — | — |
| Q3 2024 Aug 8, 2024 | $24.33M | $19.69M | -19.06% | -$0.21 | -$0.25 | -19.05% | — | — |
| Q2 2024 May 9, 2024 | $22.95M | $12.54M | -45.37% | -$0.21 | -$0.24 | -14.29% | — | — |
| Q1 2024 Mar 6, 2024 | $19.86M | $29.06M | +46.30% | -$0.23 | -$0.15 | +34.78% | — | — |
| Q4 2023 Nov 9, 2023 | $19.86M | $49.21M | +147.80% | -$0.18 | $0.07 | +138.89% | — | — |
| Q3 2023 Aug 3, 2023 | $7.94M | $22.11M | +178.41% | -$0.33 | -$0.20 | +39.39% | — | — |
| Q2 2023 May 3, 2023 | $32.33M | $12.93M | -60.01% | -$0.04 | -$0.27 | -575.00% | — | — |
| Q1 2023 Mar 22, 2023 | $7.06M | $1.24M | -82.45% | -$0.41 | -$0.47 | -14.63% | — | — |
| Q4 2022 Nov 10, 2022 | $8.20M | $285.00K | -96.52% | -$0.50 | -$0.42 | +16.00% | — | — |
| Q3 2022 Aug 11, 2022 | $3.83M | $375.00K | -90.22% | -$0.56 | -$0.62 | -10.71% | — | — |
| Q2 2022 May 12, 2022 | $3.86M | $1.75M | -54.63% | -$0.56 | -$0.62 | -10.71% | — | — |
| Q1 2022 Mar 3, 2022 | $15.79M | $1.76M | -88.82% | -$0.51 | -$0.61 | -19.61% | — | — |
| Q4 2021 Nov 10, 2021 | $59.42M | $36.42M | -38.70% | -$0.63 | -$0.12 | +80.95% | — | — |
| Q3 2021 Aug 5, 2021 | $9.79M | $2.78M | -71.64% | -$0.64 | -$0.78 | -21.88% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$0.59 | -$0.86 | -45.76% | — | — |